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Introduction
The incidence of colorectal cancer (CRC) has been increasing in developing countries worldwide, including Thailand [1] . In Thailand, CRC remains a major unsolved healthcare burden for several reasons: (1) populationbased CRC screening programs are lacking and difficult to organize, (2) the national CRC registry suffers from quality control issues, (3) there are limited budgets and few highly qualified healthcare providers to deal with CRC patients with either curative intention or palliative care, and (4) more advanced treatment approaches and facilities involving minimally invasive surgery, chemotherapy, and radiation are limited to referral university hospitals or cancer institutes. The present article aims to provide an overview of the current status of CRC in Thailand in terms of screening, fundamental treatment, and policy strategies to address the challenges described above.
Incidence and staging of CRC in Thailand
From 2000 to 2012, CRC was the only malignancy in Thailand with an increased incidence in both sexes (average annual percent changes in males = 4.1% and in females = 3.1%) regardless of geographic region [2] .
Currently, CRC is the third leading cancer in males and the fourth most common cancer in females. In 2018, 17,534 new CRC cases were detected and accounted for 10.3% of all new cancer cases in Thailand [1] . The age standardized rates of CRC in Thailand as reported by the National Cancer Institute in 2018 were 16.2/100,000 men and 11.2/100,000 women [3] . In term of age, the incidence of CRC was highest in the 60-75-year-old age group (about 50% of CRC cases). Interestingly, rectal malignancy accounts for about 40% of all CRC in Thailand [3] . Many patients with rectal cancer are referred to tertiary university hospitals or regional cancer institutes for appropriate multi-disciplinary approaches [4] , while patients with colon cancer are treated in primary and secondary hospitals.
In Thailand, the incidence of cancer staging in patients with newly diagnosed CRC is 4-9% for stage I, 17-22% for stage II, 31-37% for stage III, and 32-40% for stage IV [4, 5] . Due to lack of organized population-based CRC screening and public awareness, non-metastatic cancer accounts only for 20-30% of overall CRC cases in Thailand, while the majority of patients have nodal and/or distant metastases. Approximately one-quarter of A c c e p t e d A r t i c l e patients with rectal cancer have a permanent colostomy [6] . About 12% of CRC patients present with acute colonic obstruction with or without concomitant bowel perforation [7] .
Notably, there are three major government-based healthcare schemes in Thailand: universal coverage (covering roughly 75% of the Thai population), social security (covering about 15% of the Thai population), and the healthcare scheme for government officers (covering 10% of the Thai population). All necessary investigations and open surgery are fully reimbursed in every government-based healthcare scheme using the Thai diagnosisrelated group (DRG) system for prospective payment of inpatient care, while laparoscopy is only partially covered. 
Waiting time for surgery and number of surgeons

Growth of minimally invasive surgery for colorectal cancer in Thailand
The expanded use of minimally invasive surgery (either laparoscopy or hand-assisted laparoscopy) for CRC in Thailand can be traced back to the early 2000s -mainly in major university hospitals [8, 9] . Although laparoscopy is associated with low morbidity and shorter convalescence, a nationwide survey of Thai colorectal surgeons in 2009 found that only 40% of surgeons had performed laparoscopic proctectomy for rectal cancer due to the uncertainty of its oncological outcomes [10] . Over the last 10 years, there has been increasing evidence suggesting that there are no significant differences in oncological outcomes between laparoscopy and
A c c e p t e d A r t i c l e
an open approach to rectal cancer [11] . Accordingly, many Thai surgeons have increasingly performed minimally invasive surgery for colon and rectal malignancies, although the majority of laparoscopy for CRC is still practiced in high-volume hospitals by board-certified colorectal surgeons or well-trained laparoscopic surgeons. The total number of major operations for CRC and the percentage of laparoscopic surgery for CRC performed in some university hospitals in Thailand from 2017 to 2018 are shown in Figure 1 . From a nationwide perspective, however, there are several reasons for the slow adoption of laparoscopic surgery for CRC, including lack of well-trained laparoscopic surgeons, long learning curve, unsuitable cases (e.g., bulky tumor or locally advanced cancer), suboptimal laparoscopic equipment, and absence of reimbursement for some instruments used in laparoscopy. surgeons to serve the whole country with a population of 70 million people. It is, thus, a concern what academic society can do to improve treatment of CRC.
Roles of the Society of Colorectal Surgeons of Thailand in academic training
A c c e p t e d A r t i c l e
Increasing the number of training centers for colorectal surgery is a viable option but not a simple task; each institute must meet specific requirements to be accepted as a training center. For example, training centers are required to have at least two board-certified colorectal surgeons per trainee and at least 400 colorectal operations per annum. Improvements in teaching and practice of oncological surgery for CRC during the four-year residency program of general surgery might offer a better method of achievement, along with a postgraduate training course focusing on practical points and surgical aspects of CRC management.
Cadavers and their related workshops are an integral and important part of surgical training because they provide a meaningful simulation before encountering surgical patients -especially for minimally invasive surgery for CRC [12] . Established for more than 10 years, the Chula Soft Cadaver Surgical Training Center and 
What we have done nationally
Since CRC is one of the leading causes of cancer deaths in Thailand, the Thai Government in cooperation with the Ministry of Public Health and the National Cancer Institute of Thailand recently has paid more attention to primary and secondary prevention to control CRC. Based on a survey of current practice in CRC screening and surveillance among Thai general surgeons in 2009 [13] , fecal occult blood testing and colonoscopy were the two most popular investigations used for CRC screening in the asymptomatic, average-risk population. Most clinicians started CRC screening in individuals at the age of 50 years and did not screen populations older than 80 years. After curative CRC resection, most surgeons set up a surveillance program every three months in the first two years and performed post-CRC resection colonoscopic surveillance at one year and every three-five years thereafter [13] .
A nationwide Thailand CRC screening program was launched in October 2017, for asymptomatic participants aged 50-70 years, using a one-time quantitative fecal immunochemical test (FIT). The estimated population to be screened was 13.3 million, and the pilot project covered 1.2 million people in the first year. The initial cut-off level of FIT was 100 ng/ml, and FIT-positive individuals were invited to undergo colonoscopy. However, after a A c c e p t e d A r t i c l e preliminary analysis, it was suggested that the optimal cut-off level of FIT for CRC screening in Thailand be 150 ng/mL, because it offered both high positive and negative predictive values for advanced neoplasia detection and reduced colonoscopy workload without increasing the rate of missed CRC [14] . It is estimated that, if the entire targeted population of Thailand was enrolled in the FIT-based CRC screening program with a 70% participation rate, approximately 100,000 individuals would have a positive FIT and require colonoscopy [15] .
A pilot implementation program in the north region of Thailand found that 72% of FIT-positive individuals eventually underwent colonoscopy, revealing CRC in 3.7% and adenoma in 30.6% [16] . Although a reduction in CRC-related mortality has not been noted, our government has established another two surgical programs to support potential detection of early CRC following implementation of the nationwide CRC screening program: one-day surgery (ODS) starting in January 2018 and minimally invasive surgery (MIS) for CRC starting in January 2020. These two service platforms will provide patients with better and safer services, decreased waiting time and overcrowding in hospitals, as well as reduced healthcare costs.
Initially, the Ministry of Public Health of Thailand aims to set up at least one healthcare unit (provincial hospital excluding university hospitals and regional cancer institutes) with complete ODS and MIS platforms in each regional health area of Thailand (13 regions including Bangkok metropolitan) by 2021. Although the MIS platform for CRC in Thailand will cover laparoscopic colectomy, laparoscopic anterior resection, laparoscopic total mesorectal excision, and laparoscopic abdominoperineal resection, this program will start off with laparoscopic colectomy, which is supported and reimbursed by Thailand's universal healthcare coverage scheme.
Conclusion
The incidence of colorectal cancer in Thailand has continued to increase in both sexes. A qualified and complete nationwide registry of CRC is much needed. The cancer registry will help us not only understand the characteristics of CRC in individuals, but also contribute to their treatment, as well as research and national 
